| Entry |
|
|---|
| Name |
Warfarin potassium (JP18);
Athrombin-K (TN) |
|---|
| Formula |
C19H15O4. K
|
|---|
| Exact mass |
346.0607
|
|---|
| Mol weight |
346.4183
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01708 Coumarin anticoagulant
DG01760 Warfarin and analog
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
|
|---|
| Remark |
| Therapeutic category: | 3332 |
| Product (DG00149): | D00564<US> D01280<JP> |
|
|---|
| Efficacy |
Anticoagulant, Vitamin K antagonist |
|---|
| Comment |
Coumarin derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
|
|---|
| Metabolism |
Enzyme: CYP2C9 [HSA: 1559]
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AA Vitamin K antagonists
B01AA03 Warfarin
D01280 Warfarin potassium (JP18) <JP>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Anticoagulants
Vitamin K Antagonist
Warfarin
D01280 Warfarin potassium (JP18)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3332 Dicumarols
D01280 Warfarin potassium (JP18)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01708 Coumarin anticoagulant
DG01760 Warfarin and analog
DG00149 Warfarin
D01280 Warfarin potassium
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
DG00149 Warfarin
D01280 Warfarin potassium
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
NAD(P)H dehydrogenase
NQO1
D01280 Warfarin potassium (JP18) <JP>
Vitamin-K-epoxide reductase
VKORC1
D01280 Warfarin potassium (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01280 Warfarin potassium
D01280 Warfarin potassium tablets
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01280
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01708 Coumarin anticoagulant
DG01760 Warfarin and analog
DG00149 Warfarin
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
DG00149 Warfarin
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 24
1 C8y C 24.8561 -17.2746
2 C1c C 26.0688 -17.9857
3 C8y C 23.6435 -17.9683
4 C8y C 24.8620 -15.8811
5 C1b C 27.2872 -17.2862
6 C8y C 22.4425 -17.2570
7 O1a O 23.6376 -19.3675 #-
8 O7x O 23.6609 -15.1815
9 O6a O 26.0862 -15.1932
10 C5a C 28.4940 -17.9973
11 C8y C 22.4484 -15.8637
12 C8x C 21.2299 -17.9683
13 C1a C 28.4881 -19.4025
14 O5a O 29.7066 -17.3037
15 C8x C 21.2357 -15.1641
16 C8x C 20.0231 -17.2629
17 C8x C 20.0231 -15.8578
18 C8y C 26.0624 -19.3898
19 C8x C 24.8299 -20.0941
20 C8x C 24.8237 -21.4941
21 C8x C 26.0330 -22.1995
22 C8x C 27.2655 -21.4952
23 C8x C 27.2717 -20.0952
24 Z K 21.3765 -19.4017 #+
BOND 25
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 3 6 1
6 3 7 1
7 4 8 1
8 4 9 2
9 5 10 1
10 6 11 2
11 6 12 1
12 10 13 1
13 10 14 2
14 11 15 1
15 12 16 2
16 15 17 2
17 8 11 1
18 16 17 1
19 2 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 18 23 1
|
|---|
